Targets in the microenvironment of rectal cancer: A focus on angiogenic growth factors and chemokines

Tamas, K. R., 2015, [Groningen]: University of Groningen. 213 p.

Research output: ThesisThesis fully internal (DIV)

Copy link to clipboard


  • Title_and_contents

    Final publisher's version, 174 KB, PDF document

  • Chapter_1

    Final publisher's version, 140 KB, PDF document

  • Chapter_2

    Final publisher's version, 299 KB, PDF document

  • Chapter_3

    Final publisher's version, 424 KB, PDF document

  • Chapter_4

    Final publisher's version, 1.05 MB, PDF document

  • Chapter_5

    Final publisher's version, 1.02 MB, PDF document

  • Chapter_6

    Final publisher's version, 583 KB, PDF document

  • Chapter_7

    Final publisher's version, 103 KB, PDF document

  • Chapter_8

    Final publisher's version, 146 KB, PDF document

  • Chapter_9

    Final publisher's version, 57.9 KB, PDF document

  • Chapter_10

    Final publisher's version, 120 KB, PDF document

  • Appendices

    Final publisher's version, 82.4 KB, PDF document

  • Complete_thesis

    Final publisher's version, 2.88 MB, PDF document

  • Propositions

    Final publisher's version, 29.3 KB, PDF document

  • Karin Rita Tamas
Cancer cells interact with each other, and with cells of the tumor microenvironment. This coincides with the production of numerous soluble factors which can stimulate cancer cell growth and migration. In addition the tumor microenvironment can facilitate cancer cells to escape the effect of anticancer treatment. Understanding how the cross-talk between cancer and non-cancer cells in the tumor microenvironment mediates disease progression and resistance to treatment can potentially help to define novel and more successful treatments. In this thesis we therefore studied vessel growth factors and migration factors in metastatic rectal cancer. These patients received radiotherapy for their rectal cancer and systemic therapy including an antibody bevacizumab, that binds to the vessel growth stimulation factor VEGF-A. This treatment allowed subsequent surgical removal of the tumor in the rectum and the metastases in the liver and lungs in 72% of the patients. By examining the protein expression profile of growth and migration factors in rectal cancer cells and neighboring connecting non-cancer cells before and after the aforementioned therapy, we identified placental growth factor (PlGF) and the chemokine ligand CXCL12/ chemokine receptor CXCR4 pair as potential drug targets for rectal cancer therapy.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
Award date19-Oct-2015
Place of Publication[Groningen]
Print ISBNs978-90-367-8108-4
Electronic ISBNs978-90-367-8107-7
Publication statusPublished - 2015

Download statistics

No data available

ID: 24035877